Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer

por Liu, Kang, Graves, Joshua D., Lin, Fang-Tsyr, Lin, Weei-Chin
Publicado 2021

DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors

por Folly-Kossi, Helena, Graves, Joshua D., Garan, Lidija A. Wilhelms, Lin, Fang-Tsyr, Lin, Weei-Chin
Publicado 2023

CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer

por Lee, Yu-Ju, Ho, Shiuh-Rong, Graves, Joshua D., Xiao, Yang, Huang, Shixia, Lin, Weei-Chin
Publicado 2019